Risk Prediction Model for Surgical Complications and Predictors of Delay/Omission of Adjuvant Chemotherapy Post Primary Cytoreduction in Epithelial Ovarian Cancer-Reference-Cited by-同舟云学术

Risk Prediction Model for Surgical Complications and Predictors of Delay/Omission of Adjuvant Chemotherapy Post Primary Cytoreduction in Epithelial Ovarian Cancer

Published:2024-06-10 Issue: Volume: Page:
ISSN:0972-2068
Container-title:Indian Journal of Surgery
language:en
Short-container-title:Indian J Surg

Author:

Dahiya Alka^ORCID,George Rachel^ORCID,Thomas Anitha^ORCID,Thomas Vinotha^ORCID,Sebastian Ajit^ORCID,Peedicayil Abraham^ORCID

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s12262-024-04089-8.pdf

Reference38 articles.

1. Momenimovahed Z, Tiznobaik A, Taheri S, Salehiniya H (2019) Ovarian cancer in the world: epidemiology and risk factors. Int J Womens Health 11:287–299. https://doi.org/10.2147/IJWH.S197604

2. Lheureux S, Braunstein M, Oza AM (2019) Epithelial ovarian cancer: evolution of management in the era of precision medicine. CA Cancer J Clin. 69(4):280–304. https://doi.org/10.3322/caac.21559

3. Ledermann JA, Raja FA, Fotopoulou C, et al (2013) Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 24(Suppl 6):vi24–32. Available at: http://www.ncbi.nlm.nih.gov/pubmed/24078660

4. Benedetti Panici P, Di Donato V, Fischetti M, Casorelli A, Perniola G, Musella A et al (2015) Predictors of post-operative morbidity after cytoreduction for advanced ovarian cancer: Analysis and management of complications in upper abdominal surgery. Gynecol Oncol. 137(3):406–11. https://doi.org/10.1016/j.ygyno.2015.03.043

5. Gerestein CG, Damhuis RA, Burger CW, Kooi GS (2009) Post-operative mortality after primary cytoreductive surgery for advanced stage epithelial ovarian cancer: asystematic review. Gynecol Oncol 114(3):523–7. https://doi.org/10.1016/j.ygyno.2009.03.011